Dexcom announced today that it has secured CE Mark (Conformité Européenne) for the Dexcom G7 Continuous Glucose Monitoring (CGM) system for people with diabetes in Europe, age two years and older.
Verily, a Google company, helped Dexcom develop this new and much anticipated Dexcom G7 glucose monitor. The G7 sensor units are 60% smaller than previous models and feature an all-in-one design.
- Best companion apps for Dexcom CGMS users in 2022
- 5 common Dexcom errors and how to fix them
- The Best Diabetes management apps for your iPhone and Apple Watch in 2022
Dexcom offers direct integration with Apple Watch on the G7!
One of the salient features of this new Dexcom glucose monitoring system is that it renders all the Dexcom readings and alerts directly to a user’s Apple Watch.
This feature arrives to users later this year in a future software release. And it should dramatically help Apple Watch users view their real-time glucose readings on their Apple Watch.
Dexcom is also working closely with its insulin pump partners to integrate Dexcom G7 into current and future automated insulin delivery systems as quickly as possible.
“Over the past 20 years, Dexcom has been one of the leaders and pioneers in advancing real-time CGM technology,” said Professor Partha S. Kar, OBE, national specialty advisor, Diabetes at NHS England and consultant endocrinologist at Portsmouth Hospitals NHS Trust.
“With enhanced features and added simplicity, Dexcom G7 hopefully makes diabetes management easier for both patients and their healthcare providers, something that is especially important as we see more and more evidence of the benefits of CGM in broader populations of those living with diabetes.”
The company expects to launch the product in Europe within the next several weeks. Dexcom also announced that an updated CGM algorithm would be made available this year with potential benefits for users.